Southeastern Anatolia · Türkiye
Gastric Balloon in Şanlıurfa
Located in the GAP region of Southeastern Anatolia, Şanlıurfa is one of the region's most populous provinces, home to approximately 2.2 million people according to TÜİK ADNKS 2024 data. According to WHO 2022 modeling, Türkiye has a high obesity prevalence of 32.1% among countries in the European Region; this national picture makes access to weight management important in every region. While Şanlıurfa does not have a local authorized clinic, the Allurion Program — built around a swallowable gastric balloon — is accessible at specialized clinics in the region and in neighboring provinces.
The Allurion Program in Şanlıurfa — Key Features
No Endoscopy
The procedure is completely non-invasive. The capsule is simply swallowed with water.
15 Minutes
Placement takes 15 minutes and you return home the same day.
Digital Tracking
Six months of expert support with a smart scale and mobile app.
Şanlıurfa: a deep-rooted province of the GAP region
Şanlıurfa, located in the Southeastern Anatolia Region and one of the provinces covered by the Southeastern Anatolia Project (GAP), has a broad economic spectrum extending from agricultural production to trade. Home to approximately 2.2 million people according to TÜİK ADNKS 2024 data, the province is one of the region's densely settled centers, notable for its young population.
With districts such as Eyyübiye, Haliliye, Karaköprü, and Siverek, the province presents a structure in which urban concentration and vast rural areas exist side by side. Irrigated agriculture developed under GAP, livestock farming, and the food trade tied to them are among the key factors shaping the city's daily rhythm of life.
Şanlıurfa is also known for its deep-rooted culinary culture. A significant portion of its traditional dishes is known for high-calorie, filling content; this culinary heritage is also an inseparable part of social life and hospitality. Bordering Gaziantep, Diyarbakır, Mardin, and Adıyaman, the province sits at one of the crossroads of regional mobility.
Why weight management matters: the national picture
Across Türkiye, overweight and obesity are among the most prominent topics on the health agenda. According to the TÜİK Türkiye Health Survey 2022, the obesity rate (body mass index, or BMI, of 30 and above) among individuals aged 15 and over in Türkiye is 20.2%; this rate was measured at 23.6% in women and 16.8% in men.
In WHO 2022 modeling, which uses a different methodology, Türkiye is listed among the countries with high obesity prevalence in the European Region at 32.1%. Because these two figures are based on different methods, they should be evaluated separately; even so, both demonstrate the importance of weight management at the national scale.
There is no official, province-level obesity rate specific to Şanlıurfa; TÜİK does not publish obesity rates at the provincial or regional level. That said, factors such as the province's deep-rooted, high-calorie culinary culture, dining habits shaped around large families, the increasingly sedentary lifestyle that accompanies urbanization, and reduced daily physical activity can be counted among the qualitative factors that keep weight management on the regional agenda as well.
Healthcare infrastructure and access to clinics
Şanlıurfa is one of the provinces contributing to the region's academic and clinical capacity through Harran University and its affiliated health units. University hospitals and public health institutions provide settings where multidisciplinary approaches to obesity and weight management are developed.
In Türkiye, Ministry of Health–approved obesity centers represent a multidisciplinary standard in which different specialties — internal medicine, nutrition and dietetics, psychology, and, when needed, surgery — work together. This approach shows that weight management rests on a holistic process rather than a single procedure.
While there is no local authorized Allurion clinic in Şanlıurfa, the program is accessible at specialized clinics in the region and in neighboring provinces. Allurion has a network of more than 60 authorized centers across Türkiye; neighboring provinces that are easy to reach from Şanlıurfa can offer practical options for accessing this network.
The Allurion Program, step by step
The Allurion Program is a comprehensive structure that brings together the swallowable gastric balloon capsule, the smart scale, a mobile app, and a 6-month nutrition and behavior program. The capsule is swallowed with a glass of water in a procedure that takes approximately 15 minutes; the procedure involves no anesthesia, endoscopy, or surgery.
After placement, the balloon is filled inside the stomach and helps with portion control by supporting the feeling of fullness. The balloon empties on its own at approximately week 16 and passes naturally; no separate removal procedure is required. Throughout this period, the smart scale and mobile app make it possible to track progress together with the team overseeing follow-up.
In clinical studies, an average total body weight loss of 14.9% was reported with the Allurion Program (Ienca et al., Obes Surg 2020, N=1,770, PMID 32279182). Results vary from person to person. The FDA has granted full approval for the Allurion Balloon under PMA Class III (approval no. P250023, February 23, 2026). Eligibility is generally considered for individuals aged 18 and over with a BMI of 27 or higher; final eligibility is always determined through a physician's evaluation.
Travel and the day of the procedure
Şanlıurfa is accessible by air via GAP (Şanlıurfa) Airport, which simplifies travel planning if the program is carried out at specialized clinics in neighboring provinces. Road access to neighboring provinces such as Gaziantep, Diyarbakır, Mardin, and Adıyaman also supports regional mobility.
Because placement of the swallowable capsule requires no anesthesia or endoscopy, the procedure is usually brief. With physician approval and if one's personal circumstances allow, many people can return to their daily routine the same day; for those traveling from another province, this can also make a same-day return trip possible.
Following the nutrition and behavior program before and after the procedure is an important part of the process. Since follow-up can largely be maintained remotely thanks to the mobile app and smart scale, having the clinic in a different province is not a decisive obstacle to the continuity of the program.
Şanlıurfa — Frequently Asked Questions
Is there an authorized Allurion clinic in Şanlıurfa?
There is no local authorized Allurion clinic in Şanlıurfa. The program is accessible at specialized clinics in the region and in neighboring provinces. Allurion has a network of more than 60 authorized centers across Türkiye; neighboring provinces that are easy to reach from Şanlıurfa can offer practical options in this regard.
How much does the Allurion Program cost?
Program pricing varies from clinic to clinic and depends on a personal evaluation. No specific price is given on this page; for current, precise information, we recommend speaking directly with the authorized clinic you are interested in.
Is the procedure non-surgical?
Yes. The swallowable capsule is swallowed with a glass of water, and the procedure takes approximately 15 minutes. It involves no anesthesia, endoscopy, or surgery.
Is a separate procedure required to remove the balloon?
No. The balloon empties on its own inside the stomach at approximately week 16 and passes naturally; no separate removal procedure is required.
Who may be eligible for this program?
The program is generally considered for individuals aged 18 and over with a body mass index (BMI) of 27 or higher. Final eligibility is always determined through a physician's evaluation.
How much weight can be lost?
In clinical studies, an average total body weight loss of 14.9% was reported with the Allurion Program (Ienca et al., Obes Surg 2020, N=1,770, PMID 32279182). Results vary from person to person.
Is the Allurion Balloon approved?
The FDA has granted full approval for the Allurion Balloon under PMA Class III (approval no. P250023, February 23, 2026). This corresponds to one of the highest-level FDA approval pathways.
Sources: TÜİK Türkiye Health Survey 2022; TÜİK ADNKS 2024; WHO 2022; Ienca et al., Obes Surg 2020 (PMID 32279182, N=1,770); FDA PMA P250023 (February 23, 2026). Results vary from person to person; this content is not a substitute for medical advice. Recorded: June 2026.
Şanlıurfa: Free Assessment
Fill in the form and a specialist in the Şanlıurfa area will contact you.
Free Assessment
Let Our Specialists Call You
Let's evaluate together whether it's right for you.
Related Pages
Southeastern Anatolia Region
The Allurion Program
* Weight-loss figures are clinical group averages. Individual results may vary. Source: Ienca et al., Obes Surg 2020; PMID 32279182, N=1,770.